1.Establishment of a Carrying System for Space Cellular Experiment on Shenzhou-6 Spacecraft
Honghui WANG ; Bai DING ; Jielin NIE ; Yingjun TAN ; Yumin WAN ; Shukuan LING ; Yinghui LI
Space Medicine & Medical Engineering 2006;0(01):-
Objective To establish a carrying system for space cellular experiment suitable for astronaut to carry out cellular experiments on Shenzhou-6 mission.Methods The cell carrying sample bag,sample box and sample box integrated package were designed.Primary cardiomyocytes and osteoblasts culture and ground model experiment in the simulated environment of space cabin were performed.With man-tended,the cellular experiment was carried out on the orbit.Results After 5 d space flight,the returned cell samples were analyzed.The results demonstrated that the system was of good safety,reliability and applicability,as well as satisfied the demands of analyzed samples.Conclusion After Shenzhou-6 space flight,it is showed that this system fits for small loading,multi-cells and man-tended carrying mission,and can satisfy the demand of the first man-tended space cellular experiments carried out on the Shenzhou-6 spacecraft.
2.Effects of propofol on cognitive function in aged rats with hyperlipidemia
Xian CHEN ; Qing SUN ; Yumin ZHU ; Wei LIANG ; Tianyuan WAN ; Bocheng CHEN
Chinese Journal of Behavioral Medicine and Brain Science 2015;24(12):1070-1073
Objective To observe the effect of propofol on cognitive functions and hippocampus tissue in hyperlipidemia aged rats.Methods Seventy-six aged male SD rats were selected and randomly divided into basal diet with propofol injection (group PI), basal diet with normal saline injection(group N1), high-fat diet with propofol injection (group P2) and high-fat diet with normal saline injection (group P2), with 19 rats in each group.Eight weeks later,group P1 and P2 received intraperitoneal injection of propofol 100 mg · kg-1 · d-1 for 5 days.While in group N1 and N2, rats received the same intraperitoneal injection of equal volume normal saline.One day after the last injection, escape latency and space exploration were detected by Morris water maze in the next six days.One hour after the last water maze test, the serum and hippocampus were sampled to detect the expression of beta-amyloid protein and receptor for advanced glycation endproducts(RAGE) by immunohistochemical method and ELISA respectively.Results In place navigation tests,the escape incubation period(98.20±25.40)s in group P1 was obviously longer than that in N 1 group (47.50± 11.08) s (P< 0.01).Compared with P2 (99.79 ± 20.38) s, escape incubation period was shortened in N2 (50.70± 20.55) s (P< 0.05).There was no significantly difference between N2 and N1 (P>0.05), while the escape incubation period in group P2 was longer than P1 (P< 0.05).In spatial probe test,platform passing number ((2.86 ±1.46)times) in group P1 were less than that in N1 group ((7.50± 1.70) times, P<0.05).In group N2, the platform passing number ((6.60 ±3.91) times) were more than those in group P2 ((1.16 ±1.16)times, P<0.05) while there was no significant difference between group N1 and N2 (P>0.05).Times of crossing platform in group P2 were less than that in P1 group (P<0.05).Compared with group N1((147.83±60.88) ng/L) and N2((152.73±87.50) ng/L) ,the expression of RAGE protein was increased in group P1((629.89±110.33) ng/L) and P2((229.89±53.20) ng/L) (P<0.05).There was no significant difference between N1 and N2 groups(P>0.05) ,while the expression of RAGE protein in P1 group was lower than that of P2(P<0.05).In immunohistochemical test, positive expression cells in P1 ((18.49± 1.53) and P2 (25.67±3.08)) were higher than that in group N1(9.33±2.31) and group N2(12.14±2.52) (P<0.05) ,while there was no significant difference between group N1 and N2(P>0.05).Conclusions Anesthetic dose of propofol can injure spatial learning and memory ability in aged rats.Hyperlipidemia might act synergistically with propofol.
3.A cross-sectional study on the association between platelet-activating factor acetylhydrolase gene polymor-phism and cerebral artery atherosclerotic stenosis
Yumin CAO ; Xiong ZHANG ; Long LONG ; Xin WAN ; Shou WANG ; Chenbo DAI ; Guixian MA ; Tengyun MA ; Zhexian YANG ; Yuhu ZHANG ; Lijuan WANG
Chinese Journal of Nervous and Mental Diseases 2014;(3):138-142,148
Objective To investigate the relationship between platelet-activating factor acetylhydrolase gene Arg92His(4, 275; G→A), Ile198Thr(7, 593; T→C) and Val279Phe(9, 994; G→T) mutation and cerebral artery athero-sclerosis stenosis. Methods Six hundred forty-twopatients with cerebral infarction underwent cerebral digital subtrac-tion angiography (DSA).The patients were then divided into cerebral artery atherosclerosis stenosis (CAAS) group(n=477) and control group(n=81) accroding to the site and severity of their cerebral artery stenosis. Furthermore, the CAAS group were divided into intracranial artery stenosis(ICAS) subgroup(n=251), extracranial artery stenosis(ECAS) subgroup (n=115) and extracranial-intracerebral artery stenosis(ECAS) subgroup(n=111). The distributions of genotype and allele frequencies of Arg92His,Ile198Thr and Val279Phe mutation of platelet-activating factor acetylhydrolase gene were ex-amined and comparied in different groups. Results There were significant differences in the distributions of genotype and allele of Arg92His mutation between ICAS subgroup and control group(42.6% vs. 30.3%;23.3% vs. 16.4%, P <0.05). These associations were not detected in ECAS and IECAS subgroups. There was no significant association be-tween Ile198Thr and Val279Phe and stenosis at any site(P>0.05). The distributions of genotype and allele of Arg92His, Ile198Thr and Val279Phe mutation were no significantly difference between CAAS group and control group (P >0.05). Conclusions Arg92His mutation may be associated with intracranial artery atherosclerotic stenosis.
4.Pathologically Confirmed Subcutaneous Fat and Lymphovascular Invasion of a Hypopigmented Area in Extramammary Paget Disease
Gyoo HUH ; Ga-Young LEE ; Yumin CHUNG ; Seung-Wan CHAE ; Young-Jun CHOI
Annals of Dermatology 2023;35(Suppl2):S229-S233
Extramammary Paget disease (EMPD) is a rare adenocarcinoma that usually occurs in areas of the body that are rich in apocrine sweat glands. Great depth of tumor invasion is a well-known risk factor for worse prognosis. Paget cells usually are limited to the epidermis, whereas invasive EMPD, which infiltrates the dermis, is relatively rare. It is even rarer for the tumor to spread beyond the dermis. Only 3.1% of patients with EMPD of the penis and scrotum have exhibited infiltration of the subcutaneous fat layer. We report a case of a 62-year-old male with EMPD that invaded the subcutaneous fat layer. He presented with a several-year history of a slowly expanding erythematous plaque with the hypopigmented area on the left penoscrotum. One month before presentation, the patient had undergone punch biopsy at another hospital and diagnosed with EMPD. He had no personal history of urogenital cancers. The patient was treated with Mohs micrographic surgery, and negative margins were achieved after four stages. The histopathologic findings revealed Paget cells scattered throughout the epidermis. At the hypopigmented area, Paget cells extended to the subcutaneous fat layer with lymphovascular invasion. There was no evidence of recurrence at seven months postoperatively. Herein, we describe a case of hypopigmented EMPD that infiltrated the subcutaneous layer, which rarely has been reported in Korea.
5.A Case of Plasmodium vivax Malaria with Cerebral Complicatio.
Moonsuk KIM ; Gayeon KIM ; Yumin KANG ; Nak Hyun KIM ; Jae Hyun JEON ; Wan Beom PARK ; Hong Bin KIM ; Nam Joong KIM ; Sang Won PARK ; Yoon Ho HONG ; Myoung don OH
Infection and Chemotherapy 2009;41(5):309-313
Plasmodium vivax malaria is an endemic disease in Korea, which rarely causes severe complications including those occurring in the cerebrum. There are limited numbers of complicated cases that have been reported around the world. We experienced a case of vivax malaria with cerebral complication: cognitive impairment and ataxia. A 55-year-old female with diabetes mellitus presented to the emergency department with acute fever of two days' duration. She did not have any history of travelling abroad or receiving blood transfusions. Peripheral blood smear revealed vivax malaria with parasitemia density of 0.53 percent. She demonstrated loss of orientation, especially regarding time and place, and ataxia. Although the initial hydroxychloroquine treatment for malaria was successful, cognitive impairment and ataxia persisted and were not recovered. Brain MRI showed no structural abnormality. Brain PET showed diffuse hypometabolism in right parieto-temporal lobe of the brain.
Ataxia
;
Blood Transfusion
;
Brain
;
Cerebrum
;
Diabetes Mellitus
;
Emergencies
;
Endemic Diseases
;
Female
;
Fever
;
Humans
;
Hydroxychloroquine
;
Hypogonadism
;
Korea
;
Malaria
;
Malaria, Cerebral
;
Malaria, Vivax
;
Middle Aged
;
Mitochondrial Diseases
;
Ophthalmoplegia
;
Orientation
;
Parasitemia
;
Plasmodium
;
Plasmodium vivax
6.A Case of Plasmodium vivax Malaria with Cerebral Complicatio.
Moonsuk KIM ; Gayeon KIM ; Yumin KANG ; Nak Hyun KIM ; Jae Hyun JEON ; Wan Beom PARK ; Hong Bin KIM ; Nam Joong KIM ; Sang Won PARK ; Yoon Ho HONG ; Myoung don OH
Infection and Chemotherapy 2009;41(5):309-313
Plasmodium vivax malaria is an endemic disease in Korea, which rarely causes severe complications including those occurring in the cerebrum. There are limited numbers of complicated cases that have been reported around the world. We experienced a case of vivax malaria with cerebral complication: cognitive impairment and ataxia. A 55-year-old female with diabetes mellitus presented to the emergency department with acute fever of two days' duration. She did not have any history of travelling abroad or receiving blood transfusions. Peripheral blood smear revealed vivax malaria with parasitemia density of 0.53 percent. She demonstrated loss of orientation, especially regarding time and place, and ataxia. Although the initial hydroxychloroquine treatment for malaria was successful, cognitive impairment and ataxia persisted and were not recovered. Brain MRI showed no structural abnormality. Brain PET showed diffuse hypometabolism in right parieto-temporal lobe of the brain.
Ataxia
;
Blood Transfusion
;
Brain
;
Cerebrum
;
Diabetes Mellitus
;
Emergencies
;
Endemic Diseases
;
Female
;
Fever
;
Humans
;
Hydroxychloroquine
;
Hypogonadism
;
Korea
;
Malaria
;
Malaria, Cerebral
;
Malaria, Vivax
;
Middle Aged
;
Mitochondrial Diseases
;
Ophthalmoplegia
;
Orientation
;
Parasitemia
;
Plasmodium
;
Plasmodium vivax
7.Clinical features and treatment status of hemifacial spasm in China.
Lin WANG ; Xingyue HU ; Hongjuan DONG ; Wenzhao WANG ; Yue HUANG ; Lingjing JIN ; Yumin LUO ; Weixi ZHANG ; Yajun LIAN ; Zhanhua LIANG ; Huifang SHANG ; Yabo FENG ; Yiwen WU ; Jun CHEN ; Weifeng LUO ; Xinhua WAN
Chinese Medical Journal 2014;127(5):845-849
BACKGROUNDHemifacial spasm (HFS) is a facial nerve disorder characterized by episodic involuntary ipsilateral facial muscle contraction. Information on Chinese patients with HFS has not been well-characterized. This study aimed to evaluate the clinical feature and the treatment status of HFS across China.
METHODSA cross-sectional study including 1003 primary HFS patients had been carried out in 15 movement disorder clinics in China in 2012. The investigated information was acquired from questionnaires and medical records including demographic data, site of onset, aggravating and relieving factors, treatments prior to the investigation, etc.
RESULTSIn this study, the ratio of male to female was 1.0:1.8, the mean age at onset was (46.6 ± 11.5) years. About 1.0% patients were bilaterally affected. The most often site of initial onset was the orbicularis oculi muscle. The most often affected sites were orbicularis oculi, zygomatic, and orbicularis oris muscles. Stress/anxiety and relaxation were most often aggravating and relieving factors, respectively; 2.3% patients had family history, 28.4% cases were combined with hypertension, and 1.4% patients were with trigeminal neuralgia. Botulinum toxin type A (BTX-A) injection was the most commonly used treatment, followed by acupuncture and oral medication. BTX-A maintained the highest repeat treatment ratio (68.7%), while 98.4% patients gave up acupuncture. The mean latency of BTX-A effect was (5.0 ± 4.7) days, the mean total duration of the effect was (19.5 ± 11.7) weeks, and 95.9% patients developed improvements no worse than moderate in both severity and function. The most common side effect was droopy mouth.
CONCLUSIONSThe onset age of HFS in China is earlier than that in western countries. The most often used two treatments are BTX-A injection and acupuncture, while the latter kept the poor repeat treatment ratio because of dissatisfactory therapeutic effect.
Adult ; Botulinum Toxins, Type A ; therapeutic use ; China ; Cross-Sectional Studies ; Female ; Hemifacial Spasm ; diagnosis ; drug therapy ; Humans ; Male ; Middle Aged ; Neuromuscular Agents ; therapeutic use